CVI Holdings’s Artelo Biosciences ARTL Stock Holding History

CVI Holdings’s Portfolio ARTL Stock Details ARTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-152	Closed	-$189K	–	41
2019 Q2	$189K	Buy	+152	New	+$196K	0.22%	32

Other funds holding ARTL

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CVI Holdings's ARTL Position: Q3 2019 in Review

CVI Holdings sold out of Artelo Biosciences (ARTL) in Q3 2019, closing a stake of 152 shares — an estimated $189K sold.

CVI Holdings first reported a position in ARTL in Q2 2019 and held it in 1 quarter. The position peaked at $189K in Q2 2019. 3 funds tracked by Wall St. Rank hold ARTL as of Q3 2019.

CVI Holdings reported no remaining Artelo Biosciences position as of Q3 2019 after selling out during the quarter.
CVI Holdings sold 152 Artelo Biosciences shares in Q3 2019, an estimated $189K.
CVI Holdings first reported a position in Artelo Biosciences in Q2 2019 and held it in 1 quarter.
CVI Holdings's Artelo Biosciences position peaked at $189K in Q2 2019.
3 funds tracked by Wall St. Rank held Artelo Biosciences as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.